Ancora urges H.B. Fuller board to drop AMS bid, launch strategic review ahead of June 10 shareholder meeting

H.B. Fuller
AMANASU ENVIRONMENT CORPORATION

H.B. Fuller

FUL

0.00

AMANASU ENVIRONMENT CORPORATION

AMSU

0.00

  • Ancora, holding more than 2% of H.B. Fuller, escalated its campaign against management’s pursuit of Advanced Medical Solutions.
  • Investor urged the board to abandon the bid, citing a reversal of the March 26 pledge to prioritize deleveraging over near-term M&A.
  • Ancora warned the deal could lift leverage above 4.0x net debt to pro forma adjusted EBITDA, pressuring valuation.
  • Letter questioned management’s ability to integrate a cross-border, regulated medical products business, calling the move quasi-transformational.
  • Ancora pushed for a strategic review, including sale options, signaling a potential proxy fight next year if the board proceeds.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. H.B. Fuller Company published the original content used to generate this news brief via Business Wire (Ref. ID: 202605260830BIZWIRE_USPR_____20260526_BW137974) on May 26, 2026, and is solely responsible for the information contained therein.